UK close to US$625 million coronavirus vaccine deal with Sanofi, GSK

• According to a newspaper report, Britain was considering taking an option to buy the vaccine should it work in human trials
• An agreement with Sanofi and GSK would be the UK’s second such deal, after it said it would buy 100 million doses of the Oxford-AstraZeneca vaccine